Following the unprecedented success of mRNA technology in response to other global viral threats, researchers are now applying these flexible platforms to tuberculosis. mRNA vaccines allow for the rapid design and manufacturing of candidates that can express multiple TB antigens simultaneously. This versatility is vital because the TB bacterium is highly complex, and an effective vaccine may...